Cannabis giant Canopy Growth Corp.’s international revenue shot up to 8.2 million Canadian dollars ($6.1 million) in the nine months ended Dec. 31, a nearly sixfold increase over the same period the previous year before, according to the company’s third-quarter fiscal 2019 results.
Matt Lamers
Matt Lamers's Latest Posts
Singapore may allow scientifically proven medical cannabinoids
Singapore’s government signaled it could be ready to follow regional neighbors Thailand and South Korea in allowing pharmaceutical products containing cannabinoids.
Aurora’s European marijuana production center expects first sales in mid-2019
The first “saleable” harvest from Canadian cannabis giant Aurora’s Nordic 1 facility in Denmark is expected to be ready by the end of first quarter 2019, the company disclosed in a regulatory filing released alongside its quarterly earnings this week. Products would...
Greece challenges Denmark in race to be Europe’s marijuana hub
Greece has received as many as 30 foreign investment applications for medical and industrial cannabis production worth approximately 350 million euros ($400 million), potentially setting up the country to be the European Union’s top supplier of medical cannabis in...
Canada still plans to revoke Ascent’s marijuana license; shareholders may meet
Ascent Industries subsidiary Agrima Botanicals failed to demonstrate to federal authorities that a suspension of its cannabis licenses in Canada is unfounded, putting future operations further in doubt, the company said in a statement. Prominent shareholder Drew...
New Brunswick signs new cannabis supplier amid shortage, in talks with others
New Brunswick’s wholesaler of adult-use marijuana signed up another supplier to meet sky-high demand, and the province confirmed it is in talks with other licensed producers to fill a significant supply shortfall. Supreme Cannabis Company subsidiary 7Acres entered...
Belgium considers agency to govern medical marijuana production
Belgium’s minority government has proposed a law that calls for the establishment of a medical cannabis agency to oversee production and distribution in pharmacies, hospitals and research institutes.
Ohio cannabis firm Green Growth continues hostile bid after Aphria’s biting rejection
Green Growth Brands said it intends to continue its unsolicited takeover of Aphria even after the Canadian company’s board issued a scathing rejection of the hostile bid, saying it "could destroy value for Aphria shareholders" and calling the offer “opportunistic” and...
Health Canada suspends Bonify license after review finds it sold illegal cannabis
Health Canada suspended Bonify’s authority to sell marijuana after an investigation found the Winnipeg-based firm possessed, distributed and sold product purchased from an illegal source, the regulatory agency confirmed to Marijuana Business Daily.
In wake of Namaste fiasco, Canadian cannabis firms urged to boost corporate governance
An expert in the cannabis industry is urging Canadian marijuana companies to improve corporate governance in the wake of a controversy involving Namaste Technologies and other "unicorn" firms. Toronto-based Namaste on Monday said it removed Sean Dollinger as chief...
New Brunswick receives 11% of cannabis products ordered from cultivators ‘consistently’
New Brunswick’s cannabis wholesaler is receiving a fraction of the 352 cannabis products licensed cultivators agreed to supply the province on a regular basis, new data shows.
Canada Gets Clinical
Canada’s strict branding and packaging regulations have posed a unique challenge for cannabis companies trying to make their recreational products stand out on store shelves. The regulations limit what messages companies can deliver to consumers, given that MJ...











